Global Adalimumab Biosimilar Market Survey and Trend Research 2018

June 2018 | 82 pages | ID: GAAE6BE2DC6EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (AET BioTech, Amgen, Boehringer Ingelheim, Coherus Biosciences, LG Life Sciences/Mochida Pharmaceutical, LG Life Sciences/Mochida Pharmaceutical, Momenta Pharmaceuticals, Oncobiologics, Pfizer, Samsung Bioepsis, Sandoz, Zydus Cadila etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Adalimumab Biosimilar Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 ADALIMUMAB BIOSIMILAR MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 AET BioTech (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Amgen (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Boehringer Ingelheim (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Coherus Biosciences (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 LG Life Sciences/Mochida Pharmaceutical (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 LG Life Sciences/Mochida Pharmaceutical (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Momenta Pharmaceuticals (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Oncobiologics (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Pfizer (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Samsung Bioepsis (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Sandoz (Company Overview, Sales Data etc.)
4.12 Zydus Cadila (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Adalimumab Biosimilar Market 2012-2017, by Type, in USD Million
Table Global Adalimumab Biosimilar Market 2012-2017, by Type, in Volume
Table Global Adalimumab Biosimilar Market Forecast 2018-2023, by Type, in USD Million
Table Global Adalimumab Biosimilar Market Forecast 2018-2023, by Type, in Volume
Table AET BioTech Overview List
Table Adalimumab Biosimilar Business Operation of AET BioTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Adalimumab Biosimilar Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Adalimumab Biosimilar Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Coherus Biosciences Overview List
Table Adalimumab Biosimilar Business Operation of Coherus Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table LG Life Sciences/Mochida Pharmaceutical Overview List
Table Adalimumab Biosimilar Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table LG Life Sciences/Mochida Pharmaceutical Overview List
Table Adalimumab Biosimilar Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Momenta Pharmaceuticals Overview List
Table Adalimumab Biosimilar Business Operation of Momenta Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Oncobiologics Overview List
Table Adalimumab Biosimilar Business Operation of Oncobiologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Adalimumab Biosimilar Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Samsung Bioepsis Overview List
Table Adalimumab Biosimilar Business Operation of Samsung Bioepsis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sandoz Overview List
Table Adalimumab Biosimilar Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zydus Cadila Overview List
Table Adalimumab Biosimilar Business Operation of Zydus Cadila (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Adalimumab Biosimilar Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Adalimumab Biosimilar Sales Revenue Share, by Companies, in USD Million
Table Global Adalimumab Biosimilar Sales Volume 2012-2017, by Companies, in Volume
Table Global Adalimumab Biosimilar Sales Revenue Share, by Companies in 2017, in Volume
Table Adalimumab Biosimilar Demand 2012-2017, by Application, in USD Million
Table Adalimumab Biosimilar Demand 2012-2017, by Application, in Volume
Table Adalimumab Biosimilar Demand Forecast 2018-2023, by Application, in USD Million
Table Adalimumab Biosimilar Demand Forecast 2018-2023, by Application, in Volume
Table Global Adalimumab Biosimilar Market 2012-2017, by Region, in USD Million
Table Global Adalimumab Biosimilar Market 2012-2017, by Region, in Volume
Table Adalimumab Biosimilar Market Forecast 2018-2023, by Region, in USD Million
Table Adalimumab Biosimilar Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Adalimumab Biosimilar Industry Chain Structure
Figure Global Adalimumab Biosimilar Market Growth 2012-2017, by Type, in USD Million
Figure Global Adalimumab Biosimilar Market Growth 2012-2017, by Type, in Volume
Figure Global Adalimumab Biosimilar Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Adalimumab Biosimilar Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region